Sfoglia per RIVISTA
JOURNAL OF NEUROLOGY
Collezione AOU San Luigi di Orbassano

  

Items : 24

In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting. in Journal of neurology / J Neurol. 2024 Sep 23. doi: 10.1007/s00415-024-12701-w.

2024
AOU San Luigi di Orbassano

Malucchi S; Bava CI; Valentino P; Martire S; Lo Re M; Bertolotto A; Di Sapio A;

Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA). in Journal of neurology / J Neurol. 2024 Oct;271(10):6801-6810. doi: 10.1007/s00415-024-12621-9. Epub 2024 Aug 27.

2024
AOU San Luigi di Orbassano

Chisari CG; Amato MP; Di Sapio A; Foschi M; Iaffaldano P; Inglese M; Fermo SL; Lugaresi A; Lus G; Mascoli N; Montepietra S; Pesci I; Quatrale R; Salemi G; Torri Clerici V; Totaro R; Valentino P; Filippi M; Patti F;

The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT). in Journal of neurology / J Neurol. 2024 May;271(5):2182-2194. doi: 10.1007/s00415-024-12214-6. Epub 2024 Feb 16.

2024
AOU San Luigi di Orbassano

Bianchi A; Matranga D; Patti F; Maniscalco L; Pilotto S; Di Filippo M; Zaffaroni M; Annovazzi P; Bertolotto A; Gasperini C; Quartuccio E; Centonze D; Fantozzi R; Gajofatto A; Gobbin F; Landi D; Granella F; Buccafusca M; Marfia GA; Chisari C; Naldi P; Bergamaschi R; Greco G; Zarbo IR; Rizzo V; Ulivelli M; Bezzini D; Florio L; Turazzini M; et alii...

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.

2024
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Filippi M; Amato MP; Nica M; Ragonese P; Tortorella C; Ruggieri S; Carotenuto A; Onofrj M; Fenu G; Portaccio E; Paolicelli D; Rocca MA; Ardito B; Banfi P; Nasuelli D; Meucci G; Logullo FO; Rini A; Cargnelutti D; De Robertis F; De Riz M; Maimone D; Cavaletti G; Gazzola P; Tedeschi G; Sessa M; Rovaris M; Di Palma F; Gatto M; et alii...

ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis. in Journal of neurology / J Neurol. 2024 Jul;271(7):4057-4066. doi: 10.1007/s00415-024-12328-x. Epub 2024 Apr 3.

2024
AOU San Luigi di Orbassano

Maida E; Moccia M; Palladino R; Borriello G; Affinito G; Clerico M; Repice AM; Di Sapio A; Iodice R; Spiezia AL; Sparaco M; Miele G; Bile F; Scandurra C; Ferraro D; Stromillo ML; Docimo R; De Martino A; Mancinelli L; Abbadessa G; Smolik K; Lorusso L; Leone M; Leveraro E; Lauro F; Trojsi F; Streito LM; Gabriele F; Marinelli F; et alii...

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. in Journal of neurology / J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3.

2024
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Di Sabatino E; Clerico M; Guaschino C; Radaelli M; Fantozzi R; Buttari F; Laroni A; Gajofatto A; Calabrese M; Malucchi S; Paolicelli D; De Luca G; Tomassini V; Lanzillo R; Moccia M; Solaro C; Cocco E; Gasperini C; Tortorella C; Maniscalco GT; Gallo A; Cavalla P; Lorefice L; Nociti V; Prosperini L; Di Filippo M; Ferraro D; Ragonese P;

COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients. in Journal of neurology / J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20.

2024
AOU San Luigi di Orbassano

Gallo A; Tedeschi G; Mascolo A; Copetti M; Trojano M; Patti F; Mirabella M; Marfia GA; Lus G; Granella F; Filippi M; De Luca G; Capobianco M; Matrone F; Bisecco A;

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. in Journal of neurology / J Neurol. 2023 Oct;270(10):4687-4696. doi: 10.1007/s00415-023-11820-0. Epub 2023 Jul 5.

2023
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano

Trojano M; Filippi M; Farina A; Grassivaro N; Parodi F; Todaro DS; Sommacal S; Olivieri N; Portaccio E; Assetta M; Perini P; Baldi E; Romano M; Falcini M; Malucchi S; Leoni S; Rovaris M; Grimaldi LM; Cavalla P; Zaffaroni M; Comi C; Aguglia U; Brescia Morra V; Totaro R; Lus G; Mondino MM; Marfia GA; Mirabella M; Centonze D; et alii...

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration. in Journal of neurology / J Neurol. 2022 Mar;269(3):1463-1469. doi: 10.1007/s00415-021-10708-1. Epub 2021 Jul 22.

2022
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano

Paolicelli D; Vitetta F; Pisano E; Malucchi S; Cellerino M; Cavalla P; Patti F; Lus G; Mirabella M; Zaffaroni M; Brescia Morra V; Capobianco M; Inglese M; Guerra T; Iaffaldano P; Ferraro D; Sola P; Trojano M;

PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study. in Journal of neurology / J Neurol. 2022 Feb;269(2):933-944. doi: 10.1007/s00415-021-10676-6. Epub 2021 Jun 28.

2022
AOU Città della Salute di Torino
ASL Cuneo 1
AOU San Luigi di Orbassano

Lepore V; Solaro C; Lus G; Maimone D; Bergamaschi R; Granella F; Di Sapio A; Bertolotto A; Totaro R; Vianello M; Cavalla P; Bellantonio P; De Luca G; Cottone S; Rovaris M; Pesci I; Amato MP; Ferrò MT; Gasperini C; Maniscalco GT; Aguglia U; Sola P; Conte A; Lugaresi A; Salemi G; Paolicelli D; Iaffaldano P; Zaffaroni M; Brescia Morra V; et alii...

Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors. in Journal of neurology / J Neurol. 2022 Apr;269(4):1817-1824. doi: 10.1007/s00415-021-10782-5. Epub 2021 Sep 27.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Gallo P; Capobianco M; Filippi M; Bergamaschi R; Perini P; Puthenparampil M;

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study. in Journal of neurology / J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tomassini V; Russo M; Realmuto S; Pisa M; Perini P; Mirabella M; Manganotti P; Marfia GA; Mallucci G; Re ML; Landi D; Grimaldi LME; Gasperini C; Filippi MM; Ferraro E; Fantozzi R; Dattola V; Di Filippo M; De Luca G; Cortese A; Cavarretta R; Cavalla P; Capone F; Capobianco M; Callari G; Buscarinu MC; Borriello G; Bianchi A; Bergamaschi R; et alii...

Treatment of MOG antibody associated disorders: results of an international survey. in Journal of neurology / J Neurol. 2020 Dec;267(12):3565-3577. doi: 10.1007/s00415-020-10026-y. Epub 2020 Jul 4.

2020
AOU San Luigi di Orbassano

Wallach AI; Bennett JL; Klawiter EC; Matiello M; Greenberg B; Weinshenker BG; Wingerchuk DM; Cabre P; Tenembaum S; Sato DK; Lana-Peixoto MA; Broadley S; Boggild M; Dale RC; Ramanathan S; Fujihara K; Nakashima I; Kim HJ; Viswanathan S; Qiu W; Apiwattankul M; Hor JY; Pandit L; Akman-Demir G; Altintas A; Siva A; Illes Z; Capobianco M; Mancardi MM; et alii...

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study. in Journal of neurology / J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17.

2019
AOU San Luigi di Orbassano

Gallo A; Lapucci C; Russo CV; Bonavita S; Clerico M; Maniscalco GT; La Gioia S; Sartori A; Laroni A; Signoriello E; Capobianco M; Annovazzi P; Fenu G; Baroncini D; Saccà F; Signori A; Frau J; Carotenuto A; Sormani MP; Cocco E;

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register. in Journal of neurology / J Neurol. 2019 Dec;266(12):3098-3107. doi: 10.1007/s00415-019-09531-6. Epub 2019 Sep 18.

2019
AOU San Luigi di Orbassano

Salemi G; Salvetti M; Pozzilli C; Rovaris M; Pesci I; Patti F; Maniscalco GT; Marfia GA; Mallucci G; Maimone D; Iaffaldano P; Iaffaldano A; Lus G; Gazzola P; Gatto M; De Robertis F; Gasperini C; De Luca G; Conte A; Cocco E; Capobianco M; Brescia Morra V; Bonavita S; Avolio C; Manni A; Lucisano G; Paolicelli D; Spitaleri D; Totaro R; et alii...

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. in Journal of neurology / J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

2018
AOU San Luigi di Orbassano

Lanzillo R; Prosperini L; Gasperini C; Moccia M; Fantozzi R; Tortorella C; Nociti V; Annovazzi P; Cavalla P; Radaelli M; Malucchi S; Clerici VT; Boffa L; Buttari F; Ragonese P; Maniscalco GT; Di Filippo M; Buscarinu MC; Pinardi F; Gallo A; Coghe G; Pesci I; Laroni A; Gajofatto A; Calabrese M; Tomassini V; Cocco E; Solaro C;

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.

2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study. in Journal of neurology / J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.

2018
AOU San Luigi di Orbassano

Mallucci G; Annovazzi P; Miante S; Torri-Clerici V; Matta M; La Gioia S; Cavarretta R; Mantero V; Costantini G; D'Ambrosio V; Zaffaroni M; Ghezzi A; Perini P; Rossi S; Bertolotto A; Rottoli MR; Rovaris M; Balgera R; Cavalla P; Montomoli C; Bergamaschi R;

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. in Journal of neurology / J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.

2016
AOU San Luigi di Orbassano

Annovazzi P; Capobianco M; Moiola L; Patti F; Frau J; Uccelli A; Centonze D; Perini P; Tortorella C; Prosperini L; Lus G; Fuiani A; Falcini M; Martinelli V; Comi G; Ghezzi A;

Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia. in Journal of neurology / J Neurol. 2015 Dec;262(12):2662-7. doi: 10.1007/s00415-015-7894-1. Epub 2015 Sep 26.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M;

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.

2011
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders. in Journal of neurology / J Neurol. 2008 Sep;255(9):1315-23. doi: 10.1007/s00415-008-0879-6. Epub 2008 Sep 25.

2008
AOU San Luigi di Orbassano

Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Ferrero B; Rivoiro C; Ferrero C; Picco E; Ripellino P; Viglietti D; Giuliani G; Montanari E; Clerico M;

The importance of maintaining effective therapy in multiple sclerosis. in Journal of neurology / J Neurol. 2005 Sep;252 Suppl 3:iii38-iii43. doi: 10.1007/s00415-005-2016-0.

2005
AOU San Luigi di Orbassano

Durelli L; Clerico M;

Immunogenicity of interferon beta: differences among products. in Journal of neurology / J Neurol. 2004 Jun;251 Suppl 2:II15-II24. doi: 10.1007/s00415-004-1204-7.

2004
AOU San Luigi di Orbassano

Bertolotto A; Deisenhammer F; Gallo P; Sölberg Sørensen P;